FGF23: its role in renal bone disease
- 1 December 2006
- journal article
- review article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 21 (12) , 1802-1806
Abstract
Fibroblast growth factor 23 (FGF23) is a recently characterized peptide hormone produced mainly in the bone. It is secreted in response to dietary phosphorus load, and its main function is the promotion of urinary phosphate excretion and the suppression of active vitamin D (1,25D) production in the kidney. As such, FGF23 plays an important role in the maintenance of systemic phosphate homeostasis. In the advanced stages of chronic kidney disease (CKD), the kidney cannot excrete a phosphate load even in the presence of high levels of FGF23. This results in both hyperphosphatemia and a low level of 1,25D that stimulates the secretion of parathyroid hormone (PTH), leading to the development of secondary hyperparathyroidism. In chronic dialysis patients without residual renal function, FGF23 levels become extremely high due to stimulation by vitamin D therapy as well as by high levels of serum phosphate and PTH. Recent investigations have demonstrated that serum FGF23 level can be a useful marker for the prediction of the future development of refractory hyperparathyroidism and the response to vitamin D therapy in dialysis patients. In addition, putative protective roles of FGF23 against calcification have also been speculated on. Further elucidation of the mechanisms of FGF23 action will be needed to understand the various roles of FGF23 in CKD-Mineral and Bone Disorder (CKD-MBD).Keywords
This publication has 49 references indexed in Scilit:
- Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasiaLife Sciences, 2006
- Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure ratsKidney International, 2006
- Fibroblast Growth Factor-23 Is Regulated by 1α,25-Dihydroxyvitamin DJournal of Bone and Mineral Research, 2005
- Comparison of two assays for fibroblast growth factor (FGF)-23Journal of Bone and Mineral Metabolism, 2005
- Sevelamer Hydrochloride and Calcium Bicarbonate Reduce Serum Fibroblast Growth Factor 23 Levels in Dialysis PatientsTherapeutic Apheresis and Dialysis, 2005
- Inhibition of Intestinal Sodium‐dependent Inorganic Phosphate Transport by Fibroblast Growth Factor 23Therapeutic Apheresis and Dialysis, 2005
- Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cellsAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Fibroblast Growth Factor 23, Parathyroid Hormone, and 1α,25-Dihydroxyvitamin D in Surgically Treated Primary HyperparathyroidismMayo Clinic Proceedings, 2004
- FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate HomeostasisJournal of Bone and Mineral Research, 2004
- Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteersKidney International, 2003